Quarter Period Statement Of Income

TAKARA BIO INC. - Filing #7352210

Concept 2023-04-01 to
2023-12-31
2022-04-01 to
2022-12-31
Quarter period statement of income
Statement of income
Net sales
29,734,000,000 JPY
60,206,000,000 JPY
Cost of sales
11,692,000,000 JPY
23,771,000,000 JPY
Gross profit (loss)
18,041,000,000 JPY
36,434,000,000 JPY
Selling, general and administrative expenses
17,704,000,000 JPY
17,031,000,000 JPY
Selling, general and administrative expenses
Operating profit (loss)
336,000,000 JPY
19,403,000,000 JPY
Non-operating income
Interest income
131,000,000 JPY
98,000,000 JPY
Non-operating income
333,000,000 JPY
252,000,000 JPY
Non-operating expenses
Interest expenses
18,000,000 JPY
18,000,000 JPY
Non-operating expenses
84,000,000 JPY
175,000,000 JPY
Ordinary profit (loss)
586,000,000 JPY
19,480,000,000 JPY
Extraordinary income
Gain on sale of non-current assets
3,000,000 JPY
250,000,000 JPY
Extraordinary income
3,000,000 JPY
902,000,000 JPY
Extraordinary losses
Impairment losses
75,000,000 JPY
JPY
Extraordinary losses
88,000,000 JPY
64,000,000 JPY
Profit (loss) before income taxes
500,000,000 JPY
20,318,000,000 JPY
Income taxes - current
722,000,000 JPY
4,857,000,000 JPY
Income taxes - deferred
-399,000,000 JPY
827,000,000 JPY
Income taxes
323,000,000 JPY
5,684,000,000 JPY
Profit (loss)
177,000,000 JPY
14,633,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.